110 related articles for article (PubMed ID: 21489124)
1. Alternative splicing regulation by Muscleblind proteins: from development to disease.
Fernandez-Costa JM; Llamusi MB; Garcia-Lopez A; Artero R
Biol Rev Camb Philos Soc; 2011 Nov; 86(4):947-58. PubMed ID: 21489124
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function.
Nitschke L; Hu RC; Miller AN; Lucas L; Cooper TA
Nucleic Acids Res; 2023 Feb; 51(3):1245-1259. PubMed ID: 36617982
[TBL] [Abstract][Full Text] [Related]
3. Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis.
Cheng AW; Shi J; Wong P; Luo KL; Trepman P; Wang ET; Choi H; Burge CB; Lodish HF
Blood; 2014 Jul; 124(4):598-610. PubMed ID: 24869935
[TBL] [Abstract][Full Text] [Related]
4. Muscleblind-like proteins use modular domains to localize RNAs by riding kinesins and docking to membranes.
Hildebrandt RP; Moss KR; Janusz-Kaminska A; Knudson LA; Denes LT; Saxena T; Boggupalli DP; Li Z; Lin K; Bassell GJ; Wang ET
Nat Commun; 2023 Jun; 14(1):3427. PubMed ID: 37296096
[TBL] [Abstract][Full Text] [Related]
5. The Muscleblind-like protein MBL-1 regulates microRNA expression in Caenorhabditis elegans through an evolutionarily conserved autoregulatory mechanism.
Verbeeren J; Teixeira J; Garcia SMDA
PLoS Genet; 2023 Dec; 19(12):e1011109. PubMed ID: 38134228
[TBL] [Abstract][Full Text] [Related]
6. The role of
Penna MS; Hu RC; Rodney GG; Cooper TA
Life Sci Alliance; 2023 Jun; 6(6):. PubMed ID: 36977593
[TBL] [Abstract][Full Text] [Related]
7. Cell-type specific regulator RBPMS switches alternative splicing via higher-order oligomerization and heterotypic interactions with other splicing regulators.
Yang Y; Lee GC; Nakagaki-Silva E; Huang Y; Peacey M; Partridge R; Gooding C; Smith CWJ
Nucleic Acids Res; 2023 Oct; 51(18):9961-9982. PubMed ID: 37548402
[TBL] [Abstract][Full Text] [Related]
8. Mutation of two intronic nucleotides alters RNA structure and dynamics inhibiting MBNL1 and RBFOX1 regulated splicing of the Insulin Receptor.
Nowzari ZR; Hale M; Ellis J; Biaesch S; Vangaveti S; Reddy K; Chen AA; Berglund JA
bioRxiv; 2024 Jan; ():. PubMed ID: 38260517
[TBL] [Abstract][Full Text] [Related]
9. The HNRNPF/H RNA binding proteins and disease.
Brownmiller T; Caplen NJ
Wiley Interdiscip Rev RNA; 2023; 14(5):e1788. PubMed ID: 37042074
[TBL] [Abstract][Full Text] [Related]
10. Depolarization-mediated regulation of alternative splicing.
Sharma A; Lou H
Front Neurosci; 2011; 5():141. PubMed ID: 22207834
[TBL] [Abstract][Full Text] [Related]
11. How alternative splicing affects membrane-trafficking dynamics.
Blue RE; Curry EG; Engels NM; Lee EY; Giudice J
J Cell Sci; 2018 May; 131(10):. PubMed ID: 29769303
[TBL] [Abstract][Full Text] [Related]
12. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes.
Cerro-Herreros E; Chakraborty M; Pérez-Alonso M; Artero R; Llamusí B
Sci Rep; 2017 Jun; 7(1):2843. PubMed ID: 28588248
[TBL] [Abstract][Full Text] [Related]
13. MBNL proteins and their target RNAs, interaction and splicing regulation.
Konieczny P; Stepniak-Konieczna E; Sobczak K
Nucleic Acids Res; 2014; 42(17):10873-87. PubMed ID: 25183524
[TBL] [Abstract][Full Text] [Related]
14. Two enhancers control transcription of Drosophila muscleblind in the embryonic somatic musculature and in the central nervous system.
Bargiela A; Llamusi B; Cerro-Herreros E; Artero R
PLoS One; 2014; 9(3):e93125. PubMed ID: 24667536
[TBL] [Abstract][Full Text] [Related]
15. Novel Drosophila model of myotonic dystrophy type 1: phenotypic characterization and genome-wide view of altered gene expression.
Picchio L; Plantie E; Renaud Y; Poovthumkadavil P; Jagla K
Hum Mol Genet; 2013 Jul; 22(14):2795-810. PubMed ID: 23525904
[TBL] [Abstract][Full Text] [Related]
16. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
17. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease.
Batra R; Charizanis K; Manchanda M; Mohan A; Li M; Finn DJ; Goodwin M; Zhang C; Sobczak K; Thornton CA; Swanson MS
Mol Cell; 2014 Oct; 56(2):311-322. PubMed ID: 25263597
[TBL] [Abstract][Full Text] [Related]
18. Compound loss of muscleblind-like function in myotonic dystrophy.
Lee KY; Li M; Manchanda M; Batra R; Charizanis K; Mohan A; Warren SA; Chamberlain CM; Finn D; Hong H; Ashraf H; Kasahara H; Ranum LP; Swanson MS
EMBO Mol Med; 2013 Dec; 5(12):1887-900. PubMed ID: 24293317
[TBL] [Abstract][Full Text] [Related]
19. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models.
García-López A; Llamusí B; Orzáez M; Pérez-Payá E; Artero RD
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11866-71. PubMed ID: 21730182
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing and related RNA binding proteins in human health and disease.
Tao Y; Zhang Q; Wang H; Yang X; Mu H
Signal Transduct Target Ther; 2024 Feb; 9(1):26. PubMed ID: 38302461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
